Coloplast AS's Total Assets for the quarter that ended in Dec. 2024 was $6,787 Mil.
Warning Sign:
If a company builds assets at 39.3% a year, faster than its revenue growth rate of 8.1% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Coloplast AS's average Total Assets Growth Rate was -0.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 46.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 39.30% per year.
During the past 10 years, the average Total Assets Growth Rate was 19.40% per year.
During the past 13 years, Coloplast AS's highest 3-Year average Total Assets Growth Rate was 54.10%. The lowest was -2.20%. And the median was 7.10%.
The historical data trend for Coloplast AS's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Coloplast AS's Total Assets for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coloplast AS (OTCPK:CLPBY) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Coloplast AS's Asset Turnover for the quarter that ended in Dec. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Coloplast AS Total Assets Related Terms
Thank you for viewing the detailed overview of Coloplast AS's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLPBY has been successfully added to your 